Text Size A A A

History

Print Home » History

1950

Established in Israel to manufacture finished pharmaceutical products

1961

Started chemical synthesis (API production) in Israel

1984

Established topical product operations in Canada

1988

Taro enters the U.S. market with its first FDA-approved topical product.

2003

Established TaroPharma branded division in U.S.

2010

Sun Pharma acquires a controlling interest In Taro

2012

Over $1 Billion Gross Sales (IMS Calendar Year Sales 2012)

2012

Taro re-listed on the NYSE providing improved access to capital markets.

2022

Taro Completes Acquisition of Alchemee.

2024

On June 24, 2024, Taro became a private company and a wholly-owned subsidiary of Sun Pharma and its shares ceased to trade on the NYSE.